Integrated DNA Technologies
| Company type | Private (subsidiary of Danaher Corporation) |
|---|---|
| Industry | Biotechnology |
| Founded | 1987 |
| Founder | Joseph A. Walder, M.D., Ph.D. |
| Headquarters | Coralville, Iowa , United States |
Area served | Worldwide |
| Products | Custom DNA and RNA oligonucleotides, nucleic acid synthesis products |
| Owner | Danaher Corporation |
| Parent | Danaher Corporation |
| Website | www |
Integrated DNA Technologies, Inc. (commonly known as IDT), based in Coralville, Iowa, provides tailored nucleic acid products to sectors including academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company focuses on producing custom DNA and RNA oligonucleotides designed for various research purposes.
Established in 1987 by Joseph A. Walder, M.D., Ph.D., an alumnus of Northwestern University, IDT originated through a collaboration with Baxter Healthcare Corporation at the University of Iowa Technology Innovation Center incubator. Over its initial ten years, the firm grew from operating 10 synthesizers to more than 500, delivering roughly 75,000 custom oligos daily to a customer base exceeding 82,000 worldwide. In March 2018, Danaher Corporation acquired IDT for around $1.9 billion.
Mission
IDT's objective is to propel advancements in biology and medicine by refining nucleic acid synthesis technologies and creating innovative DNA- and RNA-based solutions. Its specialized synthesis team combines expertise in chemistry, molecular biology, and engineering to manufacture and purify complex nucleic acid molecules.
SciTools
Synthetic oligonucleotides play essential roles in molecular biology techniques such as PCR, molecular beacons, microarrays, mutagenesis, RNA interference (RNAi), antisense technology, and gene synthesis. IDT offers SciTools, a complimentary online collection of computational resources that assists molecular biologists in designing and assessing nucleic acid sequences. This platform integrates established bioinformatics algorithms to forecast oligonucleotide characteristics and assay outcomes, with continuous updates reflecting the latest developments in predictive models.
Major product areas
| DNA & RNA Synthesis | Oligonucleotide Modifications |
| Functional Genomics | Genotyping |
| Next Generation Sequencing | Gene Expression |
| Reagents | Mutation Detection |
| GMP for Molecular Diagnostics | Large Scale Oligo Synthesis |
| RNase H-dependent PCR (rhPCR) |
Certifications
In 2005, IDT secured ISO 9001:2000 certification at its primary oligonucleotide manufacturing facility, followed by achieving ISO 13485:2003 certification for its Quality Management System in 2008. These certifications highlight the company's dedication to maintaining high-quality standards in biotechnology production.